BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4622786)

  • 1. Thio-TEPA and supervoltage radiotherapy for carcinoma of the ovary.
    Deutsch M; Parsons JA
    Cancer; 1972 Apr; 29(4):1038-42. PubMed ID: 4622786
    [No Abstract]   [Full Text] [Related]  

  • 2. Surgery, chemotherapy and supervoltage radiotherapy for carcinoma of the ovary.
    Tak WK; Costanza ME; Marchant DJ; Munzenrider JE; Mitchel GW; Nathanson L; Emami B
    Int J Radiat Oncol Biol Phys; 1977; 2(9-10):895-901. PubMed ID: 412818
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of ovarian carcinoma: a review of 14 years' experience at Beth Israel Hospital.
    Blinick G; Kabakow B; Antopol W; Wallach RC
    Mt Sinai J Med; 1972; 39(5):447-57. PubMed ID: 4628079
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of Thio-TEPA on advanced ovarian cancer (author's transl)].
    Luciani L; De Palo GM; Conti U; Mattavelli F; Di Re F
    Tumori; 1973; 59(4):259-67. PubMed ID: 4357004
    [No Abstract]   [Full Text] [Related]  

  • 5. Integrated therapy in the treatment of ovarian cancer with surgery, radiation and chemotherapy.
    Speckhard ME; Hurley JD; Fetherston WC; Grueninger AJ
    Oncology; 1972; 26(2):297-309. PubMed ID: 4340440
    [No Abstract]   [Full Text] [Related]  

  • 6. The management of ovarian carcinoma--a review of 420 cases.
    Barr W; Cowell AC; Chatfield WR
    Scott Med J; 1970 Jul; 15(7):250-6. PubMed ID: 5427786
    [No Abstract]   [Full Text] [Related]  

  • 7. The changing prognosis and treatment in cancer of the ovary. A report of 235 patients with primary ovarian carcinoma 1952-1961.
    Munnell EW
    Am J Obstet Gynecol; 1968 Mar; 100(6):790-805. PubMed ID: 4296050
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer of the ovary. Survival studies based upon operative therapy, chemotherapy, and radiotherapy.
    Parker RT; Parker CH; Wilbanks GD
    Am J Obstet Gynecol; 1970 Nov; 108(6):878-88. PubMed ID: 4098756
    [No Abstract]   [Full Text] [Related]  

  • 9. [New trends in treatment of ovarian carcinoma (author's transl)].
    Janisch H; Szalay S
    Zentralbl Gynakol; 1982; 104(8):449-62. PubMed ID: 6810582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A histochemical study of Shick-positive substances in cancerous tumors of the ovaries treated with thio-TEPA].
    Kasab'ian SS; Zaĭchenko IuM
    Akush Ginekol (Mosk); 1972 Jun; 48(6):71-3. PubMed ID: 4262647
    [No Abstract]   [Full Text] [Related]  

  • 11. Factor influencing survival in Stage I ovarian cancer.
    Webb MJ; Decker DG; Mussey E; Williams TJ
    Am J Obstet Gynecol; 1973 May; 116(2):222-8. PubMed ID: 4704002
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II trial of thio-TEPA in relapsed and refractory ovarian carcinoma.
    Langer CJ; Nash S; Catalano R; Rosenblum NG; Hogan WM; Comis RL; O'Dwyer PJ
    Gynecol Oncol; 1991 Dec; 43(3):242-6. PubMed ID: 1752494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of ovarian stage-Ia carcinoma (review of 103 cases)].
    Heidenreich W; Mestwerdt W; Török M
    Zentralbl Gynakol; 1975; 97(13):791-97. PubMed ID: 1217239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy of epithelial ovarian cancer: CHexUP versus thio-tepa].
    Wu BZ
    Zhonghua Fu Chan Ke Za Zhi; 1987 Jan; 22(1):5-8, 61. PubMed ID: 3109851
    [No Abstract]   [Full Text] [Related]  

  • 15. The design of clinical trials in the therapy of ovarian carcinoma.
    Young RC; DeVita VT
    Am J Obstet Gynecol; 1974 Dec; 120(8):1012-24. PubMed ID: 4432892
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mitotic activity in ovarian serous cystadenocarcinomas treated with thio-TEPA].
    Irzhanov SI
    Akush Ginekol (Mosk); 1979 Dec; (12):38-9. PubMed ID: 119443
    [No Abstract]   [Full Text] [Related]  

  • 17. SOME OBSERVATIONS ON THE CHEMOTHERAPEUTIC PALLIATION OF INOPERABLE PRIMARY CARCINOMA OF THE OVARY USING TRIETHYLENE THIOPHOSPHORAMIDE.
    SINCLAIR WY
    Br J Clin Pract; 1964 Apr; 18():195-8. PubMed ID: 14140729
    [No Abstract]   [Full Text] [Related]  

  • 18. [The use of Thio-TEPA in patients with malignant diseases of the ovary].
    Kuz'mina NA
    Akush Ginekol (Mosk); 1966 Apr; 42(4):10-3. PubMed ID: 4965157
    [No Abstract]   [Full Text] [Related]  

  • 19. Results of treatment of primary ovarian carcinoma.
    Saarikoski S; Selander K; Kauppila O; Raitala R; Pystynen P
    Ann Chir Gynaecol; 1982; 71(3):156-60. PubMed ID: 7114781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of advanced inoperable ovarian carcinoma with thio-tepa.
    Blinick G; Kabakow B; Wallach RC; Antopol W
    Am J Obstet Gynecol; 1966 Oct; 96(3):425-9. PubMed ID: 4958483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.